Document:

Form of Voting Agreement

 Exhibit 10.2 
 FORM OF VOTING AGREEMENT 
 VOTING AGREEMENT (this “Agreement”), dated as of
June 29, 2009, by and among Cell Genesys, Inc., a Delaware corporation (“Cell Genesys”), and the undersigned stockholder (“Stockholder”) of BioSante Pharmaceuticals, Inc., a Delaware corporation (the
“Company”), identified on the signature page hereto. 
 R E C I T A L S: 
 WHEREAS, the Company and Cell Genesys are entering into an Agreement and Plan of Merger (as amended from time to time, the “Merger
Agreement”), dated as of the date hereof, providing for, among other things, the merger of Cell Genesys with and into the Company, with the Company continuing as the surviving corporation (the “Merger”); 
 WHEREAS, as of the date hereof, Stockholder is the Beneficial Owner (as defined below) of, and has the sole right to vote and dispose of, that number of
shares of common stock and Class C Special Shares (the “Company Shares”) of the Company set forth beside Stockholder’s name on Schedule A hereto; and 
 WHEREAS, concurrently with the entry by the Company and Cell Genesys into the Merger Agreement, and as a condition and inducement to the willingness of
Cell Genesys to enter into the Merger Agreement and incur the obligations set forth therein, Cell Genesys has required that Stockholder enter into this Agreement; 
 NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties, covenants and agreements contained herein, the parties hereto, intending to be legally bound, hereby agree as follows:

 ARTICLE I 
 DEFINITIONS 
 Capitalized terms used but not defined in this Agreement are used in this Agreement with the meanings given to
such terms in the Merger Agreement. In addition, for purposes of this Agreement: 
 “Affiliate” means, with respect to any
specified person, a person who, at the time of determination, directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such specified person. For purposes of this Agreement, with
respect to Stockholder, “Affiliate” shall not include the Company and the persons that directly, or indirectly through one or more intermediaries, are controlled by the Company. For the avoidance of doubt, no officer or director of
the Company shall be deemed an Affiliate of another officer or director of the Company by virtue of his or her status as an officer or director of the Company. 
 “Beneficially Owned” or “Beneficial Ownership” with respect to any securities means having beneficial ownership of such securities (as determined pursuant to Rule 13d-3 

 
under the Exchange Act, disregarding the phrase “within 60 days” in paragraph (d)(1)(i) thereof), including pursuant to any agreement,
arrangement or understanding, whether or not in writing. Without duplicative counting of the same securities, securities Beneficially Owned by a person shall include securities Beneficially Owned by (i) all Affiliates of such person, and
(ii) all other persons with whom such person would constitute a “group” within the meaning of Section 13(d) of the Exchange Act and the rules promulgated thereunder. 
 “Beneficial Owner” with respect to any securities means a person that has Beneficial Ownership of such securities. 
 “person” shall have the meaning ascribed thereto in the Merger Agreement. 
 “Subject Shares” means, with respect to Stockholder, without duplication, (i) the Company Shares owned by Stockholder on the date
hereof as described on Schedule A, and (ii) any additional Company Shares acquired by Stockholder or over which Stockholder acquires Beneficial Ownership from and after the date hereof, whether pursuant to existing stock option agreements or
otherwise. 
 “Transfer” means, with respect to a security, the sale, transfer, pledge, hypothecation, encumbrance,
assignment or disposition of such security or the Beneficial Ownership thereof, and each option, agreement, arrangement or understanding, whether or not in writing, to effect any of the foregoing. As a verb, “Transfer” shall have a
correlative meaning. 
 ARTICLE II 
 COVENANTS OF STOCKHOLDER 
 Section 2.1 Irrevocable Proxy. Concurrently with the execution of this Agreement,
Stockholder agrees to deliver to Cell Genesys a proxy in the form attached hereto as Exhibit A (the “Proxy”), which shall be irrevocable to the extent provided in Section 212 of the Delaware General Corporation Law (the
“DGCL”), with respect to the Subject Shares referred to therein. 
 Section 2.2 Agreement to Vote. 

(a) At any meeting of the stockholders of the Company held prior to the Expiration Date (as defined in Section 5.13), however called, and at every
adjournment or postponement thereof prior to the Expiration Date, or in connection with any written consent of, or any other action by, the stockholders of the Company given or solicited prior to the Expiration Date, Stockholder shall vote, or
provide a consent with respect to, all of the Subject Shares entitled to vote or to consent thereon (i) in favor of the adoption of the Merger Agreement and approval of the issuance of shares of common stock of the Company to the stockholders
of Cell Genesys pursuant to the Merger Agreement, and any actions required in furtherance thereof and (ii) against any amendment of the Company’s Certificate of Incorporation or Bylaws or any other proposal or transaction involving the
Company, the purpose of which amendment or other proposal or transaction is to delay, prevent or nullify the Merger or the transaction contemplated by the Merger Agreement or change in any manner the voting rights of any capital stock of the
Company, and against any other action or agreement that would result in a breach in any material respect of any covenant, representation or warranty or any other obligation or agreement of the Company under the Merger Agreement. 
  

 2 

 (b) Stockholder shall not enter into any agreement with any person (other than Cell Genesys) prior to the
Expiration Date (with respect to periods prior to or after the Expiration Date) directly or indirectly to vote, grant any proxy or give instructions with respect to the voting of, the Subject Shares in respect of the matters described in
Section 2.2 hereof, or the effect of which would be inconsistent with or violative of any provision contained in this Section 2.2. Any vote or consent (or withholding of consent) by Stockholder that is not in accordance with this
Section 2.2 shall be considered null and void, and the provisions of the Proxy shall be deemed to take immediate effect. 
 Section 2.3 Revocation of Proxies; Cooperation. Stockholder agrees as follows: 
 (a) Stockholder hereby
represents and warrants that any proxies heretofore given in respect of the Subject Shares with respect to the matters described in Section 2.2(a) hereof are not irrevocable, and Stockholder hereby revokes any and all prior proxies with respect
to such Subject Shares as they relate to such matters. Prior to the Expiration Date, Stockholder shall not directly or indirectly grant any proxies or powers of attorney with respect to the matters set forth in Section 2.2(a) hereof (other than
to Cell Genesys), deposit any of the Subject Shares or enter into a voting agreement (other than this Agreement) with respect to any of the Subject Shares relating to any matter described in Section 2.2(a). 
 (b) Stockholder will (i) use all reasonable efforts to cooperate with the Company and Cell Genesys in connection with the
transactions contemplated by the Merger Agreement, and (ii) provide any information reasonably requested by the Company or Cell Genesys for any regulatory application or filing sought for such transactions. 
 Section 2.4 Intentionally Omitted. 
 Section 2.5 No Transfer of Subject Shares; Publicity. Stockholder agrees that: 
 (a) Stockholder
(i) shall not Transfer or agree to Transfer any of the Subject Shares or, with respect to any matter described in Section 2.2(a), grant any proxy or power-of-attorney with respect to any of the Subject Shares, (ii) shall take all
action reasonably necessary to prevent creditors in respect of any pledge of the Subject Shares from exercising their rights under such pledge, and (iii) shall not take any action that would make in a material respect any of its representations
or warranties contained herein untrue or incorrect or would have the effect of preventing or disabling the Stockholder from performing any of its material obligations hereunder. Notwithstanding the foregoing, Stockholder may Transfer and agree to
Transfer any of the Subject Shares provided that each person to which any such Subject Shares are Transferred shall have (x) executed a counterpart of this Agreement and a Proxy in the form attached hereto as Exhibit A (with such modifications
as Cell Genesys may reasonably request), and (y) agreed in writing to hold such Subject Shares subject to all of the terms and conditions set forth in this Agreement. 
  

 3 

 (b) Unless required by applicable Law or permitted by the Merger Agreement, Stockholder
shall not, and shall not authorize or direct any of its Affiliates or Representatives to, make any press release or public announcement with respect to this Agreement or the Merger Agreement or the transactions contemplated hereby or thereby,
without the prior written consent of Cell Genesys in each instance. 
 ARTICLE III 
 REPRESENTATIONS, WARRANTIES AND ADDITIONAL COVENANTS OF STOCKHOLDER 
 Stockholder represents, warrants and covenants to Cell Genesys that: 
 Section 3.1 Ownership.
Stockholder is the sole Beneficial Owner and the record and legal owner of the Subject Shares identified on Schedule A and such shares constitute all of the capital stock of the Company Beneficially Owned by Stockholder. Stockholder has good and
valid title to all of such shares, free and clear of all Liens, claims, options, proxies, voting agreements and security interests and has the sole right to such Subject Shares and there are no restrictions on rights of disposition or other Liens
pertaining to such Subject Shares. None of the Subject Shares is subject to any voting trust or other contract with respect to the voting thereof, and no proxy, power of attorney or other authorization has been granted with respect to any of such
Subject Shares. 
 Section 3.2 Authority and Non-Contravention. 
 (a) [FOR AN INDIVIDUAL:][Stockholder is an individual, and not a corporation, limited liability company, partnership, trust or other such entity.
Stockholder has all necessary legal capacity to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby.][FOR AN ENTITY:][Stockholder is a
[            ] duly organized, validly existing and in good standing under the laws of the State of [            ]. Stockholder
has all necessary power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Stockholder and the
consummation by Stockholder of the transactions contemplated hereby have been duly and validly authorized by all necessary [corporate] action, and no other [corporate] proceedings on the part of Stockholder are necessary to authorize this Agreement
or to consummate the transactions contemplated hereby.] 
 (b) Assuming due authorization, execution and delivery of this Agreement by Cell
Genesys, this Agreement has been duly and validly executed and delivered by Stockholder and constitutes the legal, valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms except (i) to the
extent limited by applicable bankruptcy, insolvency or similar laws affecting creditors’ rights and (ii) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the
discretion of the court before which any proceeding therefor may be brought. 
  

 4 

 (c) Stockholder is not nor will it be required to make any filing with or give any notice to, or to
obtain any consent from, any person in connection with the execution, delivery or performance of this Agreement or obtain any permit or approval from any Governmental Authority for any of the transactions contemplated hereby, except to the extent
required by Section 13 or Section 16 of the Exchange Act and the rules promulgated thereunder. 
 (d) Neither the execution and
delivery of this Agreement by Stockholder nor the consummation of the transactions contemplated hereby will directly or indirectly (whether with notice or lapse of time or both) (i) conflict with, result in any violation of or constitute a
default by Stockholder under any mortgage, bond, indenture, agreement, instrument or obligation to which Stockholder is a party or by which it or any of the Subject Shares are bound, or violate any permit of any Governmental Authority, or any Law or
Order to which Stockholder, or any of the Subject Shares, may be subject, or (ii) result in the imposition or creation of any Lien upon or with respect to any of the Subject Shares; except, in each case, for conflicts, violations, defaults or
Liens that would not individually or in the aggregate be reasonably expected to prevent or materially impair or delay the performance by the Stockholder of its obligations hereunder. 
 (e) Stockholder has sole voting power and sole power to issue instructions with respect to the matters set forth in Article II hereof and sole power to
agree to all of the matters set forth in this Agreement, in each case with respect to all of the Subject Shares, with no limitations, qualifications or restrictions on such rights. 
 Section 3.3 Total Shares. Except as set forth on Schedule A, Stockholder is not the Beneficial Owner of, and does not have (whether
currently, upon lapse of time, following the satisfaction of any conditions, upon the occurrence of any event or any combination of the foregoing) any right to acquire, and has no other interest in or voting rights with respect to, any Company
Shares or any securities convertible into or exchangeable or exercisable for Company Shares. 
 Section 3.4 Reliance. Stockholder
understands and acknowledges that Cell Genesys is entering into the Merger Agreement in reliance upon Stockholder’s execution, delivery and performance of this Agreement. 
 ARTICLE IV 
 REPRESENTATIONS, WARRANTIES AND COVENANTS OF CELL GENESYS 

 Cell Genesys represents, warrants and covenants to Stockholder that, assuming due authorization, execution and delivery of this Agreement
by Stockholder, this Agreement constitutes the legal, valid and binding obligation of Cell Genesys, enforceable against Cell Genesys in accordance with its terms, except (i) to the extent limited by applicable bankruptcy, insolvency or similar
laws affecting creditors’ rights and (ii) the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor
may be brought. Cell Genesys has the corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder. The execution and delivery by Cell Genesys of this Agreement and the consummation by Cell Genesys of
the transactions contemplated hereby have been duly and validly authorized by Cell Genesys and no other corporate proceedings on the part of Cell Genesys are necessary to authorize this Agreement or to consummate the transactions contemplated
hereby. This Agreement has been duly and validly executed and delivered by Cell Genesys. 
  

 5 

 ARTICLE V 
 GENERAL PROVISIONS 
 Section 5.1 No Ownership Interest. Nothing contained in this
Agreement shall be deemed to vest in Cell Genesys or any of its Affiliates any direct or indirect ownership or incidents of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the
Subject Shares shall remain and belong to Stockholder, and neither Cell Genesys nor any of its Affiliates shall have any authority to manage, direct, superintend, restrict, regulate, govern or administer any of the policies or operations of the
Company or exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein or in the Merger Agreement. 
 Section 5.2 Notices. All notices, consents, waivers and other communications under this Agreement shall be in writing (including facsimile or
similar writing) and shall be given: 
 (a) If to Cell Genesys, to: 
 Cell Genesys, Inc. 
 400 Oyster Point
Boulevard, Suite 525 
 South San Francisco, CA 94080 
 Attention: Stephen A. Sherwin, M.D., Chairman and Chief Executive Officer 
 Facsimile No: (650) 266-3070

 with a copy (which shall not constitute notice) to: 
 Shearman & Sterling LLP 
 525 Market Street 
 San Francisco, CA 94105 
 Attention: Michael
J. Kennedy, Esq. 
                   Michael S.
Dorf, Esq. 
 Facsimile No: (415) 616-1199 
 O’Melveny & Myers LLP 
 2765 Sand Hill Road 
 Menlo Park, CA 94025 
 Attention: Sam Zucker,
Esq. 
                   Eric C. Sibbitt, Esq.

 (b) If to a Stockholder, to Stockholder’s address set forth on Schedule A. 
 or such other address or facsimile number as a party may hereafter specify for the purpose by notice to the other parties hereto. Each notice, consent, waiver or other
communication under this Agreement shall be effective only (a) if given by facsimile, when the facsimile is transmitted to the facsimile number specified in this Section and the appropriate facsimile confirmation is received or (b) if
given by overnight courier or personal delivery when delivered at the address specified in this Section. 
  

 6 

 Section 5.3 Further Actions. Upon the request of any party to this Agreement, the other party
will (a) furnish to the requesting party any additional information, (b) execute and deliver, at their own expense, any other documents and (c) take any other actions as the requesting party may reasonably require to more effectively
carry out the intent of this Agreement. 
 Section 5.4 Entire Agreement and Modification. This Agreement, the Proxy and any other
documents delivered by the parties in connection herewith constitute the entire agreement between the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, between the parties
with respect to its subject matter and constitute (along with the documents delivered pursuant to this Agreement) a complete and exclusive statement of the terms of the agreement between the parties with respect to its subject matter. This Agreement
shall not be amended, supplemented or otherwise modified except by a written document executed by the party against whose interest the modification will operate. The parties shall not enter into any other agreement inconsistent with the terms and
conditions of this Agreement and the Proxy, or that addresses any of the subject matters addressed in this Agreement and the Proxy. 
 Section 5.5 Drafting and Representation. The parties agree that the terms and language of this Agreement were the result of negotiations between the parties and, as a result, there shall be no presumption that any ambiguities in
this Agreement shall be resolved against any party. Any controversy over construction of this Agreement shall be decided without regard to events of authorship or negotiation. 
 Section 5.6 Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without affecting the validity or enforceability of the remaining provisions hereof. Any such prohibition or unenforceability in any jurisdiction shall not invalidate
or render unenforceable such provision in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as is enforceable. 
 Section 5.7 No Third-Party Rights. Stockholder may not assign any of its rights or delegate any of its obligations under this Agreement
without the prior written consent of Cell Genesys. Cell Genesys may not assign any of their rights or delegate any of their obligations under this Agreement with respect to Stockholder without the prior written consent of Stockholder. This Agreement
will apply to, be binding in all respects upon, and inure to the benefit of each of the respective successors, personal or legal representatives, heirs, distributes, devisees, legatees, executors, administrators and permitted assigns of Stockholder
and the successors and permitted assigns of Cell Genesys. Nothing expressed or referred to in this Agreement will be construed to give any person, other than the parties to this Agreement, any legal or equitable right, remedy or claim under or with
respect to this Agreement or any provision of this Agreement except such rights as may inure to a successor or permitted assignee under this Section. 
  

 7 

 Section 5.8 Enforcement of Agreement. Stockholder acknowledges and agrees that Cell Genesys
could be damaged irreparably if any of the provisions of this Agreement are not performed in accordance with their specific terms and that any breach of this Agreement by Stockholder could not be adequately compensated by monetary damages.
Accordingly, Stockholder agrees that, (a) it will waive, in any action for specific performance, the defense of adequacy of a remedy at Law, and (b) in addition to any other right or remedy to which Cell Genesys may be entitled, at Law or
in equity, Cell Genesys will be entitled to enforce any provision of this Agreement by a decree of specific performance and to temporary, preliminary and permanent injunctive relief to prevent breaches or threatened breaches of any of the provisions
of this Agreement, without posting any bond or other undertaking. 
 Section 5.9 Waiver. The rights and remedies of the parties
to this agreement are cumulative and not alternative. Neither any failure nor any delay by a party in exercising any right, power or privilege under this Agreement, the Proxy or any of the documents referred to in this Agreement will operate as a
waiver of such right, power or privilege, and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege.
To the maximum extent permitted by Law, (a) no claim or right arising out of this Agreement, the Proxy or any of the documents referred to in this Agreement can be discharged by one party, in whole or in part, by a waiver or renunciation of the
claim or right unless in a written document signed by the other party, (b) no waiver that may be given by a party will be applicable except in the specific instance for which it is given, and (c) no notice to or demand on one party will be
deemed to be a waiver of any obligation of that party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement, the Proxy or the documents referred to in this Agreement.

 Section 5.10 Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the
parties hereto will be governed by, construed under and interpreted in accordance with the Laws of the State of Delaware, without giving effect to principles of conflicts or choice of law. 
 Section 5.11 Consent to Jurisdiction. Any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out
of or in connection with, this Agreement, the Proxy or the transactions contemplated hereby or thereby shall be brought exclusively in the United States District Court for the District of Delaware or, if such court does not have jurisdiction over
the subject matter of such proceeding or if such jurisdiction is not available, in the Court of Chancery of the State of Delaware, County of New Castle, and each of the parties hereby consents to the exclusive jurisdiction of those courts (and of
the appropriate appellate courts therefrom) in any suit, action or proceeding and irrevocably waives, to the fullest extent permitted by Law, any objection which it may now or hereafter have to the laying of the venue of any suit, action or
proceeding in any of those courts or that any suit, action or proceeding which is brought in any of those courts has been brought in an inconvenient forum. Process in any suit, action or proceeding may be served on any party anywhere in the world,
whether within or without the jurisdiction of any of the named courts. Without limiting the 
  

 8 

 
foregoing, each party agrees that service of process on it by notice as provided in Section 5.2 shall be deemed effective service of process. EACH OF
THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT
OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY. 
 Section 5.12 Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed to be an original, but all of which, taken together, shall constitute one and the same instrument. This Agreement may be executed by facsimile signature (including signatures in Adobe PDF or similar
format). 
 Section 5.13 Termination. This Agreement shall terminate upon the earliest of (a) the Effective Time (as defined
in the Merger Agreement), (b) the termination of the Merger Agreement in accordance with Article IX thereof, or (c) written notice by Cell Genesys to Stockholder of the termination of this Agreement (the date of the earliest of the
events described in clauses (a), (b) and (c), the “Expiration Date”). 
 Section 5.14 Expenses. Except
as otherwise provided in this Agreement, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such expenses. 
 Section 5.15 Headings; Construction. The headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement. In this Agreement (a) words denoting the singular include the plural and vice versa, (b) “it” or “its” or words denoting any gender include all genders and (c) the
word “including” shall mean “including without limitation,” whether or not expressed. 
 [SIGNATURE PAGE FOLLOWS]

  

 9 

 IN WITNESS WHEREOF, the parties hereto have caused this Voting Agreement to be duly executed as of the
day and year first above written. 
  

					
	CELL GENESYS:	 	CELL GENESYS, INC.
			
		 	By:	 	  

		 	Name:	 	
		 	Title:	 	
		
	STOCKHOLDER:	 	[NAME]
		
		 	  

		 	Name:	 	
		
		 	Additional Signature (if held jointly):
		
		 	  

		 	(If held jointly)
		
		 	  

		 	(Printed Full Name)

  

 SCHEDULE A 
  

			
	 NAME AND
 ADDRESS OF STOCKHOLDER
	  	 COMPANY SHARES
 BENEFICIALLY OWNED

 EXHIBIT A 
 IRREVOCABLE PROXY 
 From and after the date hereof and until the Expiration Date (as defined below), the
undersigned stockholder (“Stockholder”) of BioSante Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby irrevocably (to the full extent permitted by Section 212 of the Delaware General
Corporation Law) grants to, and appoints, Cell Genesys, Inc., a Delaware corporation (“Cell Genesys”), and any designee of Cell Genesys, and each of them individually, as the sole and exclusive attorney and proxy of the undersigned,
with full power of substitution and resubstitution, to vote the Subject Shares (as defined in the Voting Agreement) of the Stockholder, or grant a consent or approval in respect of the Subject Shares of the Stockholder, in a manner consistent with
Section 2.2 of the Voting Agreement (as defined below). Upon the undersigned’s execution of this Proxy, any and all prior proxies given by the undersigned with respect to any Subject Shares relating to the voting rights expressly provided
herein are hereby revoked and the undersigned agrees not to grant any subsequent proxies with respect to the Subject Shares relating to such voting rights at any time prior to the Expiration Date. 
 This Proxy is irrevocable, is coupled with an interest and is granted pursuant to that certain Voting Agreement (as amended from time to time, the
“Voting Agreement”) of even date herewith, by and among Cell Genesys and Stockholder, and is granted in consideration of Cell Genesys entering into the Merger Agreement (as defined in the Voting Agreement). As used herein, the term
“Expiration Date,” and all capitalized terms used herein and not otherwise defined, shall have the meanings set forth in the Voting Agreement. The Stockholder agrees that this proxy shall be irrevocable until the Expiration Date
and is coupled with an interest sufficient at law to support an irrevocable proxy and given to Cell Genesys as an inducement to enter into the Merger Agreement and, to the extent permitted under applicable law, shall be valid and binding on any
person to whom Stockholder may transfer any of his, her or its Subject Shares in breach of the Voting Agreement. The Stockholder hereby ratifies and confirms all that such irrevocable proxy may lawfully do or cause to be done by virtue hereof.

 The attorneys and proxies named above, and each of them, are hereby authorized and empowered by the undersigned, at any time prior to the
Expiration Date, to act as the undersigned’s attorney and proxy to vote the Subject Shares, and to exercise all voting and other rights of the undersigned with respect to the Subject Shares (including, without limitation, the power to execute
and deliver written consents pursuant to Section 228 of the Delaware General Corporation Law), at every annual, special or adjourned meeting of the stockholders of the Company and in every written consent in lieu of such meeting in a manner
consistent with Section 2.2 of the Voting Agreement. 
 This Proxy shall be binding upon the heirs, estate, executors, personal
representatives, successors and assigns of Stockholder (including any transferee of any of the Subject Shares), and all authority herein conferred or agreed to be conferred shall survive the death or incapacity of the Stockholder. 

 If any provision of this Proxy or any part of any such provision is held under any circumstances to be
invalid or unenforceable in any jurisdiction, then (a) such provision or part thereof shall, with respect to such circumstances and in such jurisdiction, be deemed amended to conform to applicable laws so as to be valid and enforceable to the
fullest possible extent, (b) the invalidity or unenforceability of such provision or part thereof under such circumstances and in such jurisdiction shall not affect the validity or enforceability of such provision or part thereof under any
other circumstances or in any other jurisdiction, and (c) the invalidity or unenforceability of such provision or part thereof shall not affect the validity or enforceability of the remainder of such provision or the validity or enforceability
of any other provision of this Proxy. Each provision of this Proxy is separable from every other provision of this Proxy, and each part of each provision of this Proxy is separable from every other part of such provision. 
 Dated: June 29, 2009 
  

	
	  

	 (Signature of Stockholder)

	
	  

	 (Print Name of Stockholder)

	
	Number of Subject Shares owned of record or Beneficially Owned as of the date of this Proxy:
	
	  

  

 2Carnival Corporation Amended and Restated 2001 Outside Director Stock Plan

 EXHIBIT 10.1 
 CARNIVAL CORPORATION 
 AMENDED AND RESTATED 
 2001 OUTSIDE DIRECTOR STOCK PLAN 
 (Adopted by the
Board of Directors on February 16, 2001 and approved by the shareholders on April 17, 2001, effective as of January 1, 2001, amended by the Board of Directors on October 8, 2001, July 19, 2004, January 18,
2005, October 16, 2007, January 15, 2008, December 17, 2008 and April 15, 2009) 
 1. Purpose.

 The purpose of the Plan is to promote the interests of the Combined Group by strengthening the Combined Group’s ability to attract
and retain the services of experienced and knowledgeable non-executive directors and by encouraging such directors to acquire an increased proprietary interest in the Combined Group and more closely align the interests of such directors with those
of the Combined Group’s shareholders. 
 The Plan currently provides for granting of Restricted Stock Awards and Restricted Stock Unit
Awards. 
 2. Definitions. 
 The following definitions shall be applicable throughout the Plan. 
 (a) “Affiliate” means (i) any entity that
directly or indirectly is controlled by, controls or is under common control with the Company or Carnival plc, and (ii) to the extent provided by the Committee, any entity in which the Company or Carnival plc has a significant equity interest.

 (b) “Award” means, individually or collectively, any Restricted Stock Award or Restricted Stock Unit Award. 
 (c) “Award Agreement” means a Restricted Stock agreement or Restricted Stock Unit agreement. 
 (d) “Board” means the Board of Directors of the Company. 
 (e) “Carnival plc” means the entity previously known as P&O Princess Cruises plc, a public limited company incorporated under the laws of England and Wales, and any successor thereto. 
 (f) “Code” means the Internal Revenue Code of 1986, as amended. Reference in the Plan to any section of the Code shall be deemed to include any
amendments or successor provisions to such section and any regulations under such section. 
 (g) “Committee” means the
Compensation Committee of the Board. 
 (h) “Common Stock” means the common stock, par value $0.01 per share, of the Company and
any stock into which such common stock may be converted or into which it may be exchanged. 
 (i) “Combined Group” means the
Company and Carnival plc and any successor thereto. 
 (j) “Company” means Carnival Corporation, a corporation organized under the
laws of the Republic of Panama, and any successor thereto. 
 (k) “Date of Grant” means the date on which the granting of an Award
is authorized, or such other date as may be specified in such authorization or, if there is no such date, the date indicated on the applicable Award Agreement. 
 (l) “Disability means a Participant’s total disability as defined below and determined in a manner consistent with Code Section 409A and the regulations thereunder: 

 The Participant is unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months. 
 A Participant will be deemed to have suffered a Disability if determined to be totally disabled by the Social Security Administration. In addition, the Participant will be deemed to have suffered a Disability if
determined to be disabled in accordance with a disability insurance program maintained by the Company, provided that the definition of disability applied under such disability insurance program complies with the requirements of Code
Section 409A and the regulations thereunder. 
 (m) “Effective Date” means January 1, 2001. 
 (n) “Eligible Director” shall have the meaning assigned to it in Section 6. 
 (o) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 (p) “Fair Market Value”, on a given date, means (i) if the Shares are listed on a national securities exchange, the average of the highest
and lowest sale prices reported as having occurred on the primary exchange with which the Shares are listed and traded on such date, or, if there is no such sale on that date, then on the last preceding date on which such a sale was reported;
(ii) if the Shares are not listed on any national securities exchange but is quoted in the Nasdaq National Market (“Nasdaq”) on a last sale basis, the average between the high bid price and low ask price reported on the date prior to
such date, or, if there is no such sale on that date, then on the last preceding date on which a sale was reported; or (iii) if the Shares are not listed on a national securities exchange nor quoted in the Nasdaq on a last sale basis, the
amount determined by the Committee to be the fair market value based upon a good faith attempt to value the Shares accurately and computed in accordance with applicable regulations of the Internal Revenue Service. 
 (q) “Mature Shares” means Shares owned by a Participant which are not subject to any pledge or security interest and have either been held by
the Participant for six months, previously acquired by the Participant on the open market or meet such other requirements as the Committee may determine are necessary in order to avoid an accounting earnings charge on account of the use of such
Shares to pay the Option Price or satisfy any applicable withholding obligation in respect of an Option. 
 (r) “Option” means an
Award granted under Section 8 prior to January 15, 2008. 
 (s) “Option Price” means the exercise price for an Option.

 (t) “Pairing Agreement” means the Pairing Agreement, dated April 17, 2003, among the Company, The Law Debenture Trust
Corporation (Cayman) Limited, as trustee of the Carnival plc Special Voting Trust, and Sun Trust Bank, as transfer agent, as it may be amended from time to time. 
 (u) “Participant” means each Eligible Director receiving an Award pursuant to the Plan. 
 (v)
“Plan” means this Carnival Corporation Amended and Restated 2001 Outside Director Stock Plan. 
 (w) “Restricted Period”
means, with respect to any Share of Restricted Stock or any Restricted Stock Unit, the period of time during which such Award is subject to restrictions set forth in Section 9 and the applicable Award Agreement. 
 (x) “Restricted Stock” means Shares issued or transferred to a Participant subject to forfeiture and the other restrictions set forth in
Section 9 and the applicable Award Agreement. 
 (y) “Restricted Stock Award” means an Award of Restricted Stock granted under
Section 9. 

 (z) “Restricted Stock Unit” means a hypothetical investment equivalent to one Share granted in
connection with an Award made under Section 9. 
 (aa) “Restricted Stock Unit Award” means an Award of Restricted Stock Units
granted under Section 9. 
 (bb) “Securities Act” means the Securities Act of 1933, as amended. 
 (cc) “Share” means the aggregate of one share of Common Stock and one Trust Share. 
 (dd) “Stock Option Agreement” means any agreement between the Company and a Participant who has been granted an Option pursuant to
Section 8 which defines the rights and obligations of the parties thereto. 
 (ee) “Subsidiary” means any subsidiary of the
Company as defined in Section 424(f) of the Code. 
 (ff) “Trust Share” has the meaning assigned to it in the Pairing
Agreement. 
 (gg) “Vested Unit” has the meaning assigned to it in Section 9(d). 
 3. Effective Date, Duration and Shareholder Approval. 
 (a) The Plan is effective as of the Effective Date, and the Plan was approved by shareholders at a meeting held on April 17, 2001 in a manner intended to comply with the shareholder approval requirements of the
New York Stock Exchange. The Plan was amended by the Board on October 8, 2001 and July 19, 2004. The Plan was amended and restated by the Board effective as of January 18, 2005, subject to shareholder approval which was obtain
at a shareholders meeting held on April 13, 2005 in a manner intended to comply with the shareholder approval requirements of the New York Stock Exchange. The Plan was further amended by the Board on October 16, 2007, January 15,
2008, December 17, 2008 and April 15, 2009. 
 (b) The expiration date of the Plan, on and after which no Awards may be granted
hereunder, shall be January 1, 2011; provided, however, that the administration of the Plan shall continue in effect until all matters relating to Awards previously granted have been settled. 
 4. Administration. 
 (a) The Plan
shall be administered by the Committee. A majority of the Committee will constitute a quorum and the acts of a majority of the members present at any meeting at which a quorum is present, or acts approved in writing by all members of the Committee
without a meeting, will be acts of the Committee. 
 (b) Subject to the express provisions of the Plan, the Committee shall have plenary
authority to interpret the Plan, to prescribe, amend and rescind the rules and regulations relating to it and to make all other determinations deemed necessary and advisable for the administration of the Plan. No member of the Committee shall be
liable for anything done or omitted to be done by him or by any other member of the Committee in connection with the Plan, except for his own willful misconduct or gross negligence. All decisions which are made by the Committee with respect to
interpretation of the terms of the Plan and with respect to any questions or disputes arising under the Plan shall be final and binding on the Company and the participants, their heirs or beneficiaries. The Committee shall not be empowered to take
any action, whether or not otherwise authorized under the Plan, which would result in any Eligible Director failing to qualify as a “disinterested person.” 
 5. Shares Subject to Awards. 
 (a) Subject to the adjustment provisions of Section 10(e), the
aggregate number of Shares in respect of which Awards may be granted under the Plan shall not exceed 1,000,000. 

 (b) Shares shall be deemed to have been used in settlement of Awards whether or not they are actually
delivered. In the event any Award shall be surrendered, terminate, expire, be forfeited or be cancelled for any reason whatsoever without the Participant having benefited therefrom, the number of Shares no longer subject thereto shall thereupon be
released and shall thereafter be available for new Awards under the Plan. For purposes of the foregoing sentence, a Participant shall not be deemed to have received any “benefit” in the case of forfeited Restricted Stock Awards by reason
of having enjoyed voting rights and dividend rights prior to the date of forfeiture. 
 (c) Shares delivered by the Company in settlement of
Awards may be authorized and unissued Shares or Shares held in the treasury of the Company or purchased on the open market or by private purchase. 
 (d) There shall be reserved at all times for sale under the Plan a number of Shares, of either authorized and unissued Shares, Shares held in the Company’s treasury, or both, equal to the maximum number of shares in respect of which
Awards may be granted under the Plan. 
 6. Participation in Plan. Each member of the Company’s Board of Directors who is not
otherwise an employee of the Company or any Affiliate or subsidiary of the Company within the meaning of the Employee Retirement Income Security Act of 1974 (an “Eligible Director”) shall be eligible to participate in the Plan. A director
who is an employee and who retires or resigns from employment with the Company and/or its Affiliates, but remains an Eligible Director of the Company, shall become eligible to participate in the Plan in accordance with Section 7, effective as
of the first annual meeting of shareholders held after his termination of employment. 
 7. Annual Award Grants. Each Eligible
Director shall receive upon initial election to office by the shareholders and thereafter annually on the date of the Company’s annual meeting of shareholders at which such Eligible Director is re-elected to office, or on any other date
properly determined by the Board, an Award in an amount (or dollar value) determined by the Board in its sole discretion. An Award may be composed of Restricted Stock, Restricted Stock Units or a combination thereof, at the discretion of the
Committee, which discretion shall be exercised not later than the Date of Grant of such Award. Subject to the provisions of the Plan and applicable law, the Committee shall have the power, in addition to other express powers and authorizations
conferred on the Committee by the Plan, to: (i) determine the type or types of Awards to be granted to an Eligible Director; (ii) determine the number of Shares to be covered by, or with respect to which payments, rights or other matters
are to be calculated in connection with, Awards; and (iii) determine the terms and conditions of any Award. 
 8. Terms of
Options. The terms of this Section 8 shall apply to Options granted prior to January 15, 2008. 
 (a) Manner of
Exercise and Form of Payment. 
 (i) An Option granted under the Plan shall be deemed exercised when the person entitled to exercise the
Option (a) delivers written notice to the Company at its principal business office, directed to the attention of its Secretary, of the decision to exercise, specifying the number of shares with respect to which the option is exercised and the
price per share designated in the Stock Option Agreement, (b) concurrently tenders to the Company full payment for the Shares to be purchased pursuant to such exercise, and (c) complies with such other reasonable requirements as the
Committee establishes pursuant to Section 8 of the Plan. 
 (ii) Full payment for Shares purchased by the Participant shall be made at
the time of any exercise, in whole or in part, of an Option, and certificates for such Shares shall be delivered to the Participant as soon thereafter as is reasonably possible. No Shares shall be transferred to the Participant until full payment
therefor has been made and the Participant shall have none of the rights of a shareholder with respect to any Shares subject to an Option until a certificate for such shares shall have been issued and delivered to the Participant. Such payment shall
be made in cash or by check or by money order payable to the Company, in each case payable in U.S. currency. In the Committee’s discretion, such payment may be made by delivery of Mature Shares having a Fair Market Value (determined as of the
date of the Option is so exercised in whole or in part), that, when added to the value of any cash, check or money order satisfying the foregoing requirements, will equal the aggregate purchase price. 

 (b) Termination of Board Membership. 
 (i) Death or Disability. Upon a Participant’s ceasing to be a member of the Board due to death or Disability, all unvested Options shall
immediately vest and become exercisable and all vested Options shall continue to be exercisable by the Participant or his estate, as applicable, until the earlier to occur of (i) the original expiration date of such Option, and (ii) one
year from such cessation. 
 (ii) Other Termination. Except as provided in the proviso to this Section, upon a Participant’s
ceasing to be a member of the Board for any reason other than death or Disability, all unvested Options shall continue to vest in accordance with their initial terms, and all vested Options shall continue to be exercisable until the original
expiration date of such Option; provided, however, that if the Participant ceases to be a member of the Board prior to serving in such capacity for one year, all of such Participant’s Options shall immediately expire upon such
termination. 
 9. Restricted Stock and Restricted Stock Units. 
 (a) Awards of Restricted Stock and Restricted Stock Units. 
 (i) Each Participant granted a Restricted Stock Award shall execute and deliver to the Company a Restricted Stock agreement with respect to the Restricted Stock setting forth the restrictions and other terms and
conditions applicable to such Restricted Stock including the Restricted Period set forth in Section 9(c). If the Committee determines that the Restricted Stock shall be held in escrow rather than delivered to the Participant pending the release
of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (A) an escrow agreement satisfactory to the Committee and (B) the appropriate blank stock powers with respect to
the Restricted Stock covered by such agreement. If a Participant shall fail to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and stock powers, the Award shall be null and void. Subject to the
restrictions set forth in Section 9(b) and Section 9(c), the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including the right to vote such Restricted Stock. At the discretion of
the Committee, cash dividends and stock dividends with respect to the Restricted Stock may be either currently paid to the Participant or withheld by the Company for the Participant’s account, and interest may be credited on the amount of cash
dividends withheld at a rate and subject to such terms as determined by the Committee. To the extent applicable, the cash dividends or stock dividends so withheld by the Committee and attributable to any particular share of Restricted Stock (and
earnings thereon, if applicable) shall be distributed to the Participant upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such cash dividends, stock dividends or earnings.

 (ii) Upon the grant of an Award of Restricted Stock, the Committee shall cause a stock certificate registered in the name of the
Participant to be issued and, if it so determines, deposited together with the stock powers with an escrow agent designated by the Committee. If an escrow arrangement is used, the Committee may cause the escrow agent to issue to the Participant a
receipt evidencing any stock certificate held by it registered in the name of the Participant. 
 (iii) The terms and conditions of a grant
of Restricted Stock Units shall be reflected in a written Restricted Stock Unit agreement. No Shares shall be issued at the time an Award of Restricted Stock Units is made, and the Company will not be required to set aside a fund for the payment of
any such Award. At the discretion of the Committee, each Restricted Stock Unit (representing one Share) awarded to a Participant may be credited with cash and stock dividends paid by the Company in respect of one Share (“Dividend
Equivalents”). As provided in each Award, Dividend Equivalents may be either currently paid to the Participant or withheld by the Company for the Participant’s account, and interest may be credited on the amount of cash Dividend
Equivalents withheld at a rate and subject to such terms as determined by the Committee. Dividend Equivalents credited to a Participant’s account and attributable to any particular Restricted Stock Unit (and earnings thereon, if applicable)
shall be distributed to the Participant upon settlement of such Restricted Stock Unit and, if such Restricted Stock Unit is forfeited, the Participant shall have no right to such Dividend Equivalents. 

 (b) Restrictions; Forfeiture. 
 (i) Restricted Stock awarded to a Participant shall be subject to the following restrictions until the expiration of the Restricted Period, and to such
other terms and conditions as may be set forth in the applicable Restricted Stock agreement: (A) if an escrow arrangement is used, the Participant shall not be entitled to delivery of the stock certificate; and (B) the Shares shall be
subject to the restrictions on transferability set forth in the applicable Restricted Stock agreement. Restricted Stock awarded to a Participant who has not been a member of the Board for at least one year at the time of such award shall be
forfeited, and the applicable stock certificates returned to the Company, if the Participant ceases to be a member of the Board for any reason other than death or Disability prior to the one-year anniversary of his or her initial election to the
Board. In the event of such a forfeiture, all rights of the Participant to such Restricted Stock, and as a shareholder in respect thereof, shall terminate without further obligation on the part of the Company. 
 (ii) Restricted Stock Units awarded to any Participant who has not been a member of the Board for at least one year at the time of such award shall be
forfeited, and all rights of the Participant to in respect thereof, shall terminate without further obligation on the part of the Company if the Participant ceases to be a member of the Board for any reason other than death or Disability prior to
the one-year anniversary of his or her initial election to the Board. Restricted Stock Units shall be subject to such other terms and conditions as may be set forth in the applicable Restricted Stock Unit agreement. 
 (iii) The Committee shall have the authority to remove any or all of the restrictions on the Restricted Stock and Restricted Stock Units whenever it may
determine that, by reason of changes in applicable laws or other changes in circumstances arising after the date of the Restricted Stock Award or Restricted Stock Unit Award, such action is appropriate. 
 (c) Restricted Period. The Restricted Period of Restricted Stock Awards and Restricted Stock Unit Awards granted to any Participant shall commence
on the Date of Grant and shall expire as to one-hundred percent (100%) of the Restricted Stock or Restricted Stock Units, as applicable, subject thereto on each of third anniversary of the Date of Grant whether or not such Participant continues
to be a member of the Board; provided, however, that upon a Participant’s ceasing to be a member of the Board due to death or Disability, the Restricted Period shall expire as to one hundred percent (100%) of the Shares
subject thereto. 
 (d) Delivery of Restricted Stock and Settlement of Restricted Stock Units. 
 (i) Upon the expiration of the Restricted Period with respect to any Shares covered by an Award of Restricted Stock which has not been forfeited in
accordance with the second sentence of Section 9(b)(i), the restrictions set forth in this Section 9 and the Restricted Stock agreement shall be of no further force or effect with respect to shares of Restricted Stock which have not then
been forfeited. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his beneficiary, without charge, the stock certificate evidencing the shares of Restricted Stock with respect to which the
Restricted Period has expired (to the nearest full share) and any cash dividends or stock dividends credited to the Participant’s account with respect to such Restricted Stock and the interest thereon, if any. 
 (ii) Upon the expiration of the Restricted Period with respect to any Restricted Stock Units covered by a Restricted Stock Unit Award which has not been
forfeited in accordance with Section 9(b)(ii), the Company shall deliver to the Participant, or his beneficiary, without charge, one Share for each Restricted Stock Unit with respect to which the Restricted Period has expired (“Vested
Unit”) and cash equal to any Dividend Equivalents credited with respect to each such Vested Unit in accordance with Section 9(a)(iii) hereof and the interest thereon, if any; provided, however, that, if explicitly provided in
the applicable Restricted Stock Unit agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Shares in lieu of delivering only Shares for Vested Units. If a cash payment is made in lieu of delivering Shares, the
amount of such payment shall be equal to the Fair Market Value of the Shares as of the date on which the Restricted Period lapsed with respect to such Vested Unit. 

 (e) Stock Restrictions. Each certificate representing Restricted Stock awarded under the Plan
shall bear a legend substantially in the form of the following until the lapse of all restrictions with respect to the Shares subject to the Award as well as any other information the Company deems appropriate: 
 Transfer of this certificate and the shares represented hereby is restricted pursuant to the terms of the Carnival Corporation Amended and Restated 2001
Outside Director Stock Plan and a Restricted Stock Agreement, dated as of                     , between Carnival Corporation and
                    . Copies of such Plan and Agreement are on file at the offices of Carnival Corporation. 
 Stop transfer orders shall be entered with the Company’s transfer agent and registrar against the transfer of legended securities. 
 10. General. 
 (a)
Nontransferability of Awards. No Award or any right evidenced thereby shall be transferable in any manner other than by will or the laws of descent and distribution, and, during the lifetime of a Participant, only the Participant (or the
Participant’s court-appointed legal representative) may exercise an Option. In the Committee’s discretion, an Award may be transferred pursuant to a “qualified domestic relations order,” as defined in section 414(p) of the Code
or any similar domestic relations order enforceable in the jurisdiction in which such Participant resides. 
 (b) Rights of
Participant. Neither the Participant nor the Participant’s executor or administrator shall have any of the rights of a shareholder of the Company with respect to the Shares subject to an Option until certificates for such Shares shall
actually have been issued upon the due exercise of such Option. No adjustment shall be made for any regular cash dividend for which the record date is prior to the date of such due exercise and full payment for such Shares has been made therefor.

 (c) Right To Terminate Relationship. Nothing in the Plan or in any Award shall confer upon any Participant the right to continue to
serve as a director of the Company. 
 (d) Nonalienation of Benefits. No right or benefit under the Plan shall be subject to
anticipation, alienation, sale, assignment, hypothecation, pledge, exchange, transfer, encumbrance or charge, and any attempt to anticipate, alienate, sell, assign, hypothecate, pledge, exchange, transfer, encumber or charge the same shall be void.
To the extent permitted by applicable law, no right or benefit hereunder shall in any manner be liable for or subject to the debts, contracts, liabilities or torts of the person entitled to such benefits. 
 (e) Adjustment Upon Changes in Capitalization, etc. 
 (i) Awards granted under the Plan, any Award Agreements, and the maximum number of Shares subject to all Awards stated in Section 5(a) shall be subject to adjustment or substitution, as determined by the
Committee in its sole discretion, as to the number, price or kind of a share of stock or other consideration subject to such Awards or as otherwise determined by the Committee to be equitable in the event of any stock split, stock dividend, stock
change, reclassification, an unpairing of the shares of Common Stock from the Trust Shares, recapitalization or combination of shares which changes the character or amount of Shares (x) in the case of Options, prior to exercise of any portion
of an Option theretofore granted under the Plan, such that such option, to the extent that it shall not have been exercised, shall entitle the Participant (or the Participant’s executor or administrator) upon its exercise to receive in
substitution therefor such number and kind of shares as the Participant would have been entitled to receive if the Participant had actually owned the Shares subject to such Option at the time of the occurrence of such change; provided,
however, that if the change is of such a nature that the Participant, upon exercise of the Option, would receive property other than shares of stock the Committee shall make an appropriate adjustment in the Option to provide that the
Participant (or the Participant’s executor or administrator) shall acquire upon exercise only shares of stock of such number and kind as the Committee, in its sole judgment, shall deem equitable; and, provided further, that any such
adjustment shall be made so as to conform to the 

 
requirements of section 424(a) of the Code; and (y) in the case of Restricted Stock and Restricted Stock Units, occurring after the Date of Grant of any
such Awards. 
 (ii) In the event that any transaction (other than a change specified in the preceding paragraph) described in section
424(a) of the Code affects the Shares subject to any unexercised Option or subject to any Award with respect to which the Restricted Period has not expired, the Board of Directors of the surviving or acquiring corporation shall make such similar
adjustment as is permissible and appropriate. If any such change or transaction shall occur, the number and kind of Shares for which Awards may thereafter be granted under the Plan shall be adjusted to give effect thereto. 
 (f) Purchase for Investment. Whether or not the Options and Shares covered by the Plan have been registered under the Securities Act of 1933, each
person exercising an Option under the Plan may be required by the Company to give a representation in writing that such person is acquiring such Shares for investment and not with a view to, or for sale in connection with, the distribution of any
part thereof. The Company will endorse any necessary legend referring to the foregoing restriction upon the certificate or certificates representing any Shares issued or transferred to the Participant upon the exercise of any Option granted under
the Plan. 
 (g) Form of Agreements with Participants. Each Award granted pursuant to the Plan shall be in writing and shall have such
form, terms and provisions, not inconsistent with the provisions of the Plan, as the Committee shall provide for such Award. Each Participant shall be notified promptly of such grant, and an Award shall be promptly executed and delivered by the
Company and the Participant. 
 (h) Termination and Amendment of Plan and Awards. 
 (i) Unless the Plan shall theretofore have been terminated as hereinafter provided, Awards may be granted under the Plan at any time, and from time to
time, prior to the tenth anniversary of the Effective Date, on which date the Plan will expire, except as to Awards then outstanding under the Plan. Such Awards shall remain in effect until they have been exercised, have expired or have been
canceled. 
 (ii) The Board, without further approval of the Company’s shareholders, may terminate, modify or amend this Plan at any
time and from time to time in such respects as the Board may deem advisable, subject to any shareholder or regulatory approval required by law or the New York Stock Exchange; provided, that any such amendment shall comply with the applicable
requirements for exemption (to the extent necessary) under Rule 16b-3 under the Exchange Act. 
 (iii) No termination, modification or
amendment of the Plan, without the consent of the Participant, may adversely affect the rights of such person with respect to such Award. With the consent of the Participant and subject to the terms and conditions of the Plan, the Committee may
amend outstanding Award agreements with any Participant. 
 (iv) Notwithstanding the above, without shareholder approval, the Committee may
not take any action that results in the “repricing” of any Option granted under the Plan. For purposes of this Section 10(h)(iv), a “repricing” means any of the following (or any other action that has the same effect of any
of the following): (a) amending or modifying the terms of an Option after the Date of Grant in a manner that reduces the Option Price of such Option; (b) any other action that would either (A) be reportable on the Company’s proxy
statement as Options which have been “repriced” (as such term is used in Item 402 of Regulation S-K promulgated under the Exchange Act) or (B) results in an Option being considered repriced under generally accepted accounting
principles; or (c) canceling an Option at time when its Option Price is equal to or less than the Fair Market Value of the Shares subject to the Option, in exchange for another Option, Restricted Stock Award, Restricted Stock Unit Award, or any
other equity-based award. A cancellation and exchange described in clause (c) of the preceding sentence will be considered a “repricing” regardless of whether (A) the Option, Restricted Stock Award, Restricted Stock Unit Award,
or other equity-based award is delivered simultaneously with the cancellation of the Option, (B) it is reportable as a repricing in the Company’s proxy statement or under generally accepted accounting principles, or (C) the
cancellation of the Option was voluntary on the part of the Participant. 

 (i) Government and Other Regulations. The obligation of the Company with respect to Awards granted
under the Plan shall be subject to all applicable laws, rules and regulations and such approvals by any governmental agency as may be required, including, without limitation, the effectiveness of any registration statement required under the
Securities Act, the rules and regulations of any securities exchange on which the Shares may be listed. 
 (j) Withholding. A
Participant may be required to pay to a member of the Combined Group or any Affiliate, and each member of the Combined Group or any Affiliate shall have the right and is hereby authorized to withhold from any Shares or other property deliverable
under any Award or from any compensation or other amounts owing to a Participant the amount (in cash, Shares or other property) of any required tax withholding in respect of an Award, its exercise, or any payment or transfer under an Award or under
the Plan and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes. 
 (k) Separability. If any of the terms or provision of the Plan conflict with the requirements of Rule 16b-3 under the Exchange Act, then such terms or provisions shall be deemed inoperative to the extent they so conflict with the
requirements of Rule 16b-3. 
 (i) Governing Law. The Plan shall be governed by and construed in accordance with the internal laws of
the State of Florida without regard to the principles of conflicts of law thereof, or principles of conflicts of laws of any other jurisdiction which could cause the application of the laws of any jurisdiction other than the State of Florida.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]